Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G U Corsini

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal of Neurochemistry|August 1, 1992
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primatesA Zuddas, G Oberto, F Vaglini, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonismR Maggio, M Riva, F Vaglini, et al.
Archives of Neurology|January 1, 1978
Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptorG U Corsini, P Onali, C Masala, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in miceF Vaglini, F Fascetti, D Tedeschi, et al.
Journal of Neural Transmission. Supplementum|November 7, 2007
CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicityC Viaggi, F Vaglini, C Pardini, et al.
Biochemical Pharmacology|November 1, 1988
Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivoG U Corsini, A Bocchetta, A Zuddas, et al.
Journal of Neurochemistry|June 1, 1990
[3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterizationM Del Zompo, S Ruiu, R Maggio, et al.
Clinical Neuropharmacology|October 1, 1991
Naloxone partly counteracts apomorphine side effectsU Bonuccelli, P Piccini, P Del Dotto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Apomorphine test for dopaminergic responsiveness: a dose assessment studyU Bonuccelli, P Piccini, P Del Dotto, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1978
Apomorphine as a preferential stimulant of self-inhibitory dopamine receptors in manG U Corsini, M Del Zompo, M P Piccardi, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of Neurochemistry|August 1, 1992
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primatesA Zuddas, G Oberto, F Vaglini, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonismR Maggio, M Riva, F Vaglini, et al.
Archives of Neurology|January 1, 1978
Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptorG U Corsini, P Onali, C Masala, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in miceF Vaglini, F Fascetti, D Tedeschi, et al.
Journal of Neural Transmission. Supplementum|November 7, 2007
CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicityC Viaggi, F Vaglini, C Pardini, et al.
Biochemical Pharmacology|November 1, 1988
Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivoG U Corsini, A Bocchetta, A Zuddas, et al.
Journal of Neurochemistry|June 1, 1990
[3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterizationM Del Zompo, S Ruiu, R Maggio, et al.
Clinical Neuropharmacology|October 1, 1991
Naloxone partly counteracts apomorphine side effectsU Bonuccelli, P Piccini, P Del Dotto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Apomorphine test for dopaminergic responsiveness: a dose assessment studyU Bonuccelli, P Piccini, P Del Dotto, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1978
Apomorphine as a preferential stimulant of self-inhibitory dopamine receptors in manG U Corsini, M Del Zompo, M P Piccardi, et al.
Pageof 8